---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-095296"
form_type: "8-K"
ticker: "CGON"
cik: "0001991792"
company_name: "CG Oncology, Inc."
filed_at: "2025-07-11T23:59:59+00:00"
generated_at: "2026-05-18T06:59:47.198697+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CFO Corleen Roche resigns effective Aug 5; Robert Lapetina named interim principal financial officer

## Summary
- CFO Corleen Roche resigns effective August 5, 2025.
- Robert Lapetina, VP FP&A since May 2024, appointed interim principal financial and accounting officer.
- Lapetina previously VP Finance and Controller at Immunome, Inc. and roles at Chubb, Teleflex, Pfizer.

## SEC filing metadata
- accession: 0000950170-25-095296
- form_type: 8-K
- ticker: CGON
- cik: 0001991792
- company_name: CG Oncology, Inc.
- filed_at: 2025-07-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1991792/000095017025095296/0000950170-25-095296-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1991792/000095017025095296/ck0001991792-20250707.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-095296
- JSON: https://secwatch.observer/filing/0000950170-25-095296.json
- Plain text: https://secwatch.observer/filing/0000950170-25-095296.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.